Alisertib Inhibits Migration and Invasion of EGFR-TKI Resistant Cells by Partially Reversing the Epithelial-Mesenchymal Transition.
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research（2021）
Key words
AURKA,Alisertib,EGFR,TKI resistance,Epithelial-mesenchymal transition,Non-small cell lung cancer
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined